Metacavir

CAS No. 120503-45-9

Metacavir( —— )

Catalog No. M34334 CAS No. 120503-45-9

Metacavir (PNA) is a novel nucleoside reverse transcriptase inhibitor, a deoxyguanosine analog, with anti-hepatitis B virus (HBV) activity and mitochondrial toxicity, which can be used to study HBV infection.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
100MG 2484 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Metacavir
  • Note
    Research use only, not for human use.
  • Brief Description
    Metacavir (PNA) is a novel nucleoside reverse transcriptase inhibitor, a deoxyguanosine analog, with anti-hepatitis B virus (HBV) activity and mitochondrial toxicity, which can be used to study HBV infection.
  • Description
    Metacavir (PNA) is a novel nucleoside reverse transcriptase inhibitor, a deoxyguanosine analog, with anti-hepatitis B virus (HBV) activity and mitochondrial toxicity, which can be used to study HBV infection.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HBV
  • Recptor
    HBV | Reverse Transcriptase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    120503-45-9
  • Formula Weight
    265.27
  • Molecular Formula
    C11H15N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C)C1=C2C(N(C=N2)[C@@H]3O[C@H](CO)CC3)=NC(N)=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JNJ-632

    JNJ-632 (JNJ632) is a novel potent HVV capsid assembly modulator and HBV replication inhibitor.

  • HEC72702

    HEC72702 is a novel potent, orally active inhibitor of HBV capsid assembly, inhibits HBV-DNA levels in HepG.2.2.15 cells with IC50 of 39 nM.

  • AT-130

    AT-130 is a potent inhibitor of HBV capsid assembly, inhibits wild-type HBV replication with IC50 of 2.4 uM.